Journal article Open Access
Martens, Géraldine; Laureys, Steven; Thibaut, Aurore
{ "publisher": "Zenodo", "DOI": "10.5281/zenodo.1194506", "container_title": "Brain Sciences", "title": "SpasticityManagement in Disorders of Consciousness", "issued": { "date-parts": [ [ 2018, 3, 8 ] ] }, "abstract": "<p>Background: Spasticity is a motor disorder frequently encountered after a lesion involving<br>\nthe central nervous system. It is hypothesized to arise from an anarchic reorganization of the<br>\npyramidal and parapyramidal fibers and leads to hypertonia and hyperreflexia of the affected<br>\nmuscular groups. While this symptom and its management is well-known in patients suffering from<br>\nstroke, multiple sclerosis or spinal cord lesion, little is known regarding its appropriate management<br>\nin patients presenting disorders of consciousness after brain damage. Objectives: Our aim was to<br>\nreview the occurrence of spasticity in patients with disorders of consciousness and the therapeutic<br>\ninterventions used to treat it. Methods: We conducted a systematic review using the PubMed online<br>\ndatabase. It returned 157 articles. After applying our inclusion criteria (i.e., studies about patients in<br>\ncoma, unresponsive wakefulness syndrome or minimally conscious state, with spasticity objectively<br>\nreported as a primary or secondary outcome), 18 studies were fully reviewed. Results: The prevalence<br>\nof spasticity in patients with disorders of consciousness ranged from 59% to 89%. Current treatment<br>\noptions include intrathecal baclofen and soft splints. Several treatment options still need further<br>\ninvestigation; including acupuncture, botulin toxin or cortical activation by thalamic stimulation.<br>\nConclusion: The small number of articles available in the current literature highlights that spasticity<br>\nis poorly studied in patients with disorders of consciousness although it is one of the most common<br>\nmotor disorders. While treatments such as intrathecal baclofen and soft splints seem effective,<br>\nlarge randomized controlled trials have to be done and new therapeutic options should be explored.</p>", "author": [ { "family": "Martens, G\u00e9raldine" }, { "family": "Laureys, Steven" }, { "family": "Thibaut, Aurore" } ], "type": "article-journal", "id": "1194506" }
All versions | This version | |
---|---|---|
Views | 33 | 33 |
Downloads | 35 | 35 |
Data volume | 33.2 MB | 33.2 MB |
Unique views | 33 | 33 |
Unique downloads | 35 | 35 |